Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- Check5 days agoChange DetectedNew version entries appear in the Record History, adding more submitted changes and showing updates to study status and locations.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference12%

- Check41 days agoChange DetectedThe page now shows revision v3.1.0, replacing v3.0.2. This is a version update with no other content changes.SummaryDifference0.3%

- Check55 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.7%

- Check62 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.7%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference15%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.